日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Increased level of TXNIP and nuclear translocation of TXN is associated with end stage renal disease and development of multiplex renal tumours

TXNIP 水平升高和 TXN 核易位与终末期肾病和多发性肾肿瘤的发展有关

Tamas Beothe, Janos Docs, Gyula Kovacs, Lehel Peterfi

Lack of VEGFA/KDR Signaling in Conventional Renal Cell Carcinoma Explains the Low Efficacy of Target Therapy and Frequent Adverse Events

常规肾细胞癌缺乏 VEGFA/KDR 信号传导,导致靶向治疗疗效低下且不良事件频发

Lehel Peterfi, Maria V Yusenko, Gyula Kovacs, Tamas Beothe

End-stage kidney disease: a never healing wound leading to another never healing wound, renal cancer

终末期肾病:一个永不愈合的伤口导致另一个永不愈合的伤口——肾癌

Janos Docs, Gyula Kovacs, Lehel Peterfi

FAPα and αSMA mark different subsets of fibroblasts in normal kidney and conventional renal cell carcinoma

FAPα 和 αSMA 标记正常肾脏和常规肾细胞癌中的不同亚群成纤维细胞

Lehel Peterfi, Maria V Yusenko, Gyula Kovacs, Tamas Beothe

Matrix metalloproteinase 12 is an independent prognostic factor predicting postoperative relapse of conventional renal cell carcinoma - a short report

基质金属蛋白酶 12 是预测常规肾细胞癌术后复发的独立预后因素 - 简短报告

Bence Beres, Maria Yusenko, Lehel Peterfi, Gyula Kovacs, Daniel Banyai

Expression of RARRES1 and AGBL2 and progression of conventional renal cell carcinoma

RARRES1 和 AGBL2 的表达与常规肾细胞癌的进展

Lehel Peterfi, Daniel Banyai, Maria V Yusenko, Thea Bjercke, Gyula Kovacs

Shift of Keratin Expression Profile in End-stage Kidney Increases the Risk of Tumor Development

终末期肾脏角蛋白表达谱的转变增加了肿瘤发展的风险

Donat Peter Sarlos, Lehel Peterfi, Arpad Szanto, Gyula Kovacs